Pharma Skeptical of US FDA Plan for OTC Indications of Prescription Drugs
A group of pharma industry organizations have banded together and leveled their complaints and concerns at the US Food… Read more
HEOR Feature
Featured
No Word from US FDA on Orphan Drug Exclusivity
The US Food and Drug Administration (FDA) is maintaining silence after losing a case last year over exclusivity of an orphan drug. In the case, and… Read more
Twist Biosciences Unveils Factory It Says Could Make Biologic Prices Competitive
Twist Biosciences, a biotech specializing in DNA synthesis, has revealed details of its new, state-of-the-art facilities the company says may drive… Read more
Pharma Skeptical of US FDA Plan for OTC Indications of Prescription Drugs
A group of pharma industry organizations have banded together and leveled their complaints and concerns at the US Food and Drug Administration’s… Read more
The Latest Blogs from tHEORetically Speaking
- Getting Real About Real-World Data
- How might digitization change health care in Germany by 2035, Julian Molitor?
- Are selective contracts with German insurances a smarter reimbursement pathway, Tim Hering?
- Would AI substitute or (only) support market access managers, Dr. Andree Bates?
- Using Real-World Data for Patients with Multiple Sclerosis: A New Machine Learning Model for the Expanded Disability Status Scale (EDSS)
